You can now read 10 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

The Boston Globe

Business

FDA approves new Biogen MS drug

Federal regulators on Wednesday approved Biogen Idec Inc.’s first pill to treat multiple sclerosis, cementing the Weston company’s dominance in MS treatments and potentially allowing thousands of patients to stop taking their drugs by needle or intravenous infusions.

Biogen Idec already markets two of the best-selling injectable MS treatments and had long sought Food and Drug Administration approval to sell the new drug, called Tecfidera, in the United States.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week